Success Metrics

Clinical Success Rate
86.4%

Based on 165 completed trials

Completion Rate
86%(165/191)
Active Trials
7(2%)
Results Posted
21%(34 trials)
Terminated
26(9%)

Phase Distribution

Ph phase_2
126
44%
Ph not_applicable
16
6%
Ph phase_1
38
13%
Ph phase_3
92
32%
Ph early_phase_1
3
1%

Phase Distribution

41

Early Stage

126

Mid Stage

92

Late Stage

Phase Distribution275 total trials
Early Phase 1First-in-human
3(1.1%)
Phase 1Safety & dosage
38(13.8%)
Phase 2Efficacy & side effects
126(45.8%)
Phase 3Large-scale testing
92(33.5%)
N/ANon-phased studies
16(5.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

79.7%

165 of 207 finished

Non-Completion Rate

20.3%

42 ended early

Currently Active

7

trials recruiting

Total Trials

285

all time

Status Distribution
Active(8)
Completed(165)
Terminated(42)
Other(70)

Detailed Status

Completed165
unknown69
Terminated26
Withdrawn16
Active, not recruiting4
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
285
Active
7
Success Rate
86.4%
Most Advanced
Phase 3

Trials by Phase

Early Phase 13 (1.1%)
Phase 138 (13.8%)
Phase 2126 (45.8%)
Phase 392 (33.5%)
N/A16 (5.8%)

Trials by Status

withdrawn166%
suspended10%
not_yet_recruiting10%
completed16558%
terminated269%
unknown6924%
active_not_recruiting41%
recruiting31%

Recent Activity

Clinical Trials (285)

Showing 20 of 285 trialsScroll for more
NCT00433420Phase 3

Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer

Active Not Recruiting
NCT03567889Phase 3

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

Recruiting
NCT04567420Phase 2

DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)

Recruiting
NCT00766142Phase 2

Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer

Terminated
NCT07089199Phase 2

Tislelizumab Combined With Anlotinib and Nab-paclitaxel in III Resectable Non-small Cell Lung Cancer(TitAN) : A Prospective, Single-Arm, Phase II Study

Not Yet Recruiting
NCT07067268Phase 2

Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy

Recruiting
NCT00354393Phase 2

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

Completed
NCT02401685Not Applicable

POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer

Active Not Recruiting
NCT00667069Phase 3

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

Completed
NCT00059930Phase 1

Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer

Completed
NCT00544414Phase 2

Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer

Completed
NCT00667121

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Completed
NCT00559156Phase 2

Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Completed
NCT06775652Phase 3

Neoadjuvant Chemoradiotherapy Plus Surgery vs. Surgery Plus Adjuvant Therapy for ESCC

Completed
NCT00796978Phase 2

Trastuzumab in Treating Older Women With Early-Stage Breast Cancer

Completed
NCT00006256Phase 2

Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer

Completed
NCT00541047Phase 3

RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery

Completed
NCT00499083Phase 2

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

Completed
NCT00089024Phase 2

Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Completed
NCT00006478Phase 2

Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma

Terminated

Drug Details

Intervention Type
PROCEDURE
Total Trials
285